ORBIT Bleeding Risk Score for Atrial Fibrillation

The ORBIT bleeding risk score is a five‑factor tool estimating major bleeding risk in atrial fibrillation patients on anticoagulation 1 [Level I evidence].

Sex, Hb or Hct
Neither0Female, Hb < 12 or hct < 36%+2Male, Hb < 13 or hct < 40%+2
Age > 74 years
No0Yes+1
Bleeding history
No0Yes+2
GFR < 60 mL/min/1.73 m2
No0Yes+1
Treatment with antiplatelet agents
No0Yes+1

Indications for Use

Used in adults with AF being considered for oral anticoagulation to estimate major bleeding risk and to highlight modifiable factors. Identifies higher‑risk patients using five predictors and offers modest discrimination (c‑index ≈0.67 in external validation) 1 [Level I evidence]. Best used to guide mitigation of reversible risks rather than to withhold anticoagulation.

Insights & Cautions

Identifies major bleeding risk using five items but offers only modest discrimination and poor calibration in NOAC users, with tendency to under‑classify high‑risk patients. Validation studies show AUC ~0.60 and worse calibration than HAS‑BLED 1. Current guidelines caution that no bleeding score should guide anticoagulation decisions and should instead be used only to identify modifiable risk factors 2.